坎伯兰制药是一家专科制药企业,专注于开发、生产和商业化品牌处方药物,核心产品覆盖急症护理、胃肠病、疼痛管理及罕见病治疗领域,主要运营市场为美国,为相关医护人员与患者提供服务。
XLO
Xilio Therapeutics, Inc.
营收
$13.7M
净利润
$10.4M
KALV
KalVista Pharmaceuticals, Inc.
$-49.5M
NRIX
Nurix Therapeutics, Inc.
$13.6M
$-78.2M
MBCN
MIDDLEFIELD BANC CORP
$19.9M
$5.3M
GOSS
Gossamer Bio, Inc.
$13.8M
$-47.2M
ASRT
Assertio Holdings, Inc.
$13.5M
N/A
VFF
Village Farms International, Inc.
$12.2M
$2.4M
OCUL
OCULAR THERAPEUTIX, INC
$13.3M
$-64.7M